diacetyldichlorofluorescein has been researched along with paclitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, B; Yuan, Y | 1 |
| Srinivasan, P; Vanajothi, R | 1 |
2 other study(ies) available for diacetyldichlorofluorescein and paclitaxel
| Article | Year |
|---|---|
Self-assembled nanoparticles based on PEGylated conjugated polyelectrolyte and drug molecules for image-guided drug delivery and photodynamic therapy.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Electrolytes; Fluoresceins; Humans; Image Processing, Computer-Assisted; Nanoparticles; Paclitaxel; Photochemotherapy; Polyethylene Glycols; Reactive Oxygen Species | 2014 |
An anthraquinone derivative from Luffa acutangula induces apoptosis in human lung cancer cell line NCI-H460 through p53-dependent pathway.
Topics: Anthraquinones; Apoptosis; Ataxia Telangiectasia Mutated Proteins; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; DNA Fragmentation; Fluoresceins; Gene Expression Regulation, Neoplastic; Humans; Intracellular Space; Luffa; Lung Neoplasms; Models, Biological; Molecular Docking Simulation; Molecular Dynamics Simulation; NF-kappa B; Nuclear Proteins; Paclitaxel; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Tumor Suppressor Protein p53 | 2016 |